497 / 1084
Case Report
Tumor board decision and clinical course:
03-05/2015
3 x ECX
(d1 epirubicin 50mg/m
2
, cisplatin 60mg/m
2
,
d1-21 capecitabine 2x 625mg/m
2
)
during neoadjuvant chemotherapy, some episodes of dyspnoea
04/2015
cardiac catheterization, to rule out unstable angina
CT-scan, to rule out pulmonary embolism
06/2015
surgery: extended gastrectomy with transhiatal
resection of the distal esophagus and D2(?)-lymphadenectomy
ypT
3
, pN
1(1/14)
, G
1
, L
1
, R
0
,
reconstruction: end-to-side esophagojejunostomy with
roux-en-Y reconstruction
histology showed no regression (Becker score 3)
07/2015
follow-up, no adjuvant chemotherapy